- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: INGAP Peptide
Total 2255 results
-
Sun Yat-sen UniversityUnknownDiabetes Mellitus, Type 2
-
Marcus BorchertBoehringer Ingelheim; ikfe-CRO GmbHUnknown
-
Nagaoka Red Cross HospitalUnknownType 2 Diabetes MellitusJapan
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941United States
-
Pharmaceutical Research Unit, JordanCompleted
-
Hospices Civils de LyonRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingGastric Cancer | Diffuse Type CarcinomaChina
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Thailand, United Kingdom, Malaysia, New Zealand, Taiwan, Turkey, Canada, Mexico, Israel, India, Argentina, Brazil, Russian Federation, Australia, Korea, Republic of, Italy, Philippines, Colombia, Poland, Chile, Finland and more
-
Merck Sharp & Dohme LLCCompleted
-
University of Southern CaliforniaCompletedInflammation | AtherosclerosisUnited States
-
Samsung Medical CenterNovartisCompletedType 2 Diabetes MellitusKorea, Republic of
-
Merck Sharp & Dohme LLCCompleted
-
Boryung Pharmaceutical Co., LtdCompleted
-
University of British ColumbiaMerck Sharp & Dohme LLCTerminatedIslet TransplantationCanada
-
Medical College of WisconsinMerck Sharp & Dohme LLCCompletedDiabetes | AtherosclerosisUnited States
-
TakedaCompletedDiabetes Mellitus, Type 2United States
-
Profil Institut für Stoffwechselforschung GmbHCompletedType 2 Diabetes MellitusGermany
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States, Chile, Argentina, Brazil, Canada, Mexico, Puerto Rico, Taiwan, Australia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Finland, Israel, Japan, New Zealand, Slovakia, Sweden
-
Boehringer IngelheimCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Italy, United Kingdom, Finland, Norway, Mexico, Austria, Denmark, Germany, Hungary, Greece, France, Spain
-
Boehringer IngelheimCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
-
TakedaCompleted
-
TakedaCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2United States, Germany
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
AstraZenecaBristol-Myers SquibbCompletedDiabetes Mellitus, Type 2United States, Mexico, Canada, United Kingdom, India, Belgium, Taiwan
-
vTv TherapeuticsCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2 | Chronic Renal Insufficiency
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina
-
SanofiCompletedDiabetes Mellitus, Type 2Mexico, Guatemala
-
CelltrionCompleted
-
Sichuan Haisco Pharmaceutical Group Co., LtdCompletedDiabetes Mellitus, Type 2China
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)